The nocebo effect challenges the non-medical infliximab switch in practice. [PDF]
Eur J Clin Pharmacol, 2018 Boone NW +10 more
europepmc +1 more source
The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies. [PDF]
J Manag Care Spec Pharm, 2018 Odinet JS, Day CE, Cruz JL, Heindel GA.
europepmc +1 more source
Nocebo effects in long-term health conditions: a systematic review of experimental studies. [PDF]
Front PsychiatryChurch BA +4 more
europepmc +1 more source
Beyond expectations: nocebo suggestion affects cognitive performance in older adults. [PDF]
Psychol ResBarbon A +4 more
europepmc +1 more source
The "Are You OK?" Paradox: A Scoping Review of Nocebo and Negative Suggestion in Healthcare Communication. [PDF]
Dent J (Basel)O'Brien OK, Donnell CC.
europepmc +1 more source
Can Nocebo Effects Be Reduced via Open- and Closed-Label Counterconditioning? [PDF]
Eur J PainMeijer S +3 more
europepmc +1 more source
Verbal modeling, counterconditioning, and operant conditioning are effective in nocebo hyperalgesia attenuation. [PDF]
PainRubanets D +4 more
europepmc +1 more source
Cyberchondria in the Spinal Surgery Pathway: A Scoping Review of its Impact on Preoperative Distress and Postoperative Pain Outcomes. [PDF]
Global Spine JKarami M +5 more
europepmc +1 more source
Editorial: Optimizing the therapeutic potential in clinical settings: leveraging placebos and mitigating nocebo effects. [PDF]
Front PsycholFaria V +4 more
europepmc +1 more source